Big Pharma Split Corp.
PRM.TO · TSX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CA$0 | CA$0 | CA$0 | CA$0 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$0 | CA$0 | CA$0 | CA$0 |
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 493.1% | -92.1% | -26.7% | – |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 82.9% | 100% | 89.3% | 93.4% |
| EBITDA | CA$0 | -CA$0 | CA$0 | CA$0 |
| % Margin | 1.2% | -44.1% | 80.1% | 90.6% |
| Net Income | -CA$0 | -CA$0 | CA$0 | CA$0 |
| % Margin | -29.1% | -44.8% | 80.1% | 90.6% |
| EPS Diluted | -0.47 | -0.53 | 1.58 | 3.27 |
| % Growth | 11.3% | -133.5% | -51.7% | – |
| Operating Cash Flow | -CA$0 | CA$0 | CA$0 | -CA$0 |
| Capital Expenditures | CA$0 | -CA$0 | CA$0 | CA$0 |
| Free Cash Flow | -CA$0 | CA$0 | CA$0 | -CA$0 |